Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Bristol Myers Squibb Co (BMYMP) AI Forecast

Our AI analyzed Bristol Myers Squibb Co. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$BMYMP Neutral Signal Full forecast available
Sign Up Free

Bristol Myers Squibb Co (BMYMP) Stock Forecast 2025

Bristol Myers Squibb Co (BMYMP) AI Stock Price Forecast & Investment Analysis

Bristol Myers Squibb Co Stock Price Chart and Technical Analysis

Loading chart...

Bristol Myers Squibb Co (BMYMP) - Comprehensive Stock Analysis & Investment Research

Deep dive into Bristol Myers Squibb Co's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on May 2, 2026, 9:04 a.m. (UTC)

Bristol Myers Squibb Co Investment Summary

When evaluating whether Bristol Myers Squibb Co (BMYMP) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Bristol Myers Squibb Co (BMYMP) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $1733 billion, the company is classified as a mega-cap stock, typically characterized by high stability and strong institutional backing.

Financial Performance Analysis

Our comprehensive financial analysis covers Bristol Myers Squibb Co's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Bristol Myers Squibb Co along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Bristol Myers Squibb Co is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Bristol Myers Squibb Co

Sign Up Free
Corporate Identity

Bristol Myers Squibb Co (Stock Symbol: BMYMP) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Bristol Myers Squibb Co's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Bristol Myers Squibb Co...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Bristol Myers Squibb Co...

Unlock Full Company Profile

Get complete details about Bristol Myers Squibb Co

Sign Up Free
Revenue & Growth Analysis

Bristol Myers Squibb Co generates annual revenues of $48 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Bristol Myers Squibb Co...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Bristol Myers Squibb Co...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Bristol Myers Squibb Co...

Unlock Financial Analysis

Get complete financial metrics for Bristol Myers Squibb Co

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Bristol Myers Squibb Co's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Bristol Myers Squibb Co strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a mega-cap market leader, the company commands significant market influence, enjoying substantial competitive moats including brand recognition, scale economies, and extensive distribution networks. Mega-cap status typically brings advantages in capital access, talent acquisition, and partnership opportunities, while also attracting the highest levels of institutional investor and analyst coverage.

Industry Competitive Landscape

Bristol Myers Squibb Co competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Bristol Myers Squibb Co (BMYMP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Bristol Myers Squibb Co stock analysis.

Deep dive into Bristol Myers Squibb Co's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Bristol Myers Squibb Co stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Bristol Myers Squibb Co: With a P/E ratio of 286.99, the market highly values future growth prospects.

P/E Ratio 286.99x
P/B Ratio 93.42x
Market Cap $1.73T
EPS $2.49
Book Value/Share $9.10
Revenue/Share $23.56
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Bristol Myers Squibb Co converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Bristol Myers Squibb Co:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Bristol Myers Squibb Co's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Bristol Myers Squibb Co:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Bristol Myers Squibb Co's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Bristol Myers Squibb Co:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Bristol Myers Squibb Co uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Bristol Myers Squibb Co:

Understanding Financial Statement Data

What these metrics mean: Key figures from Bristol Myers Squibb Co's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Bristol Myers Squibb Co: With annual revenue of $48034M, Bristol Myers Squibb Co operates at significant scale.

Income Statement
Total Revenue $48.03B
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 2039M

Latest Bristol Myers Squibb Co Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Bristol Myers Squibb Co (BMYMP) stock price and investment outlook.

source: Chron

The Princeton, New Jersey-based company said it had net income of $1.31 per share. Earnings, adjusted for one-time gains and costs, came to $1.58 per share. The results beat Wall Street expectations.

More news available

Sign up free to read all 12 news articles and stay updated on market developments.

Sign Up Free to Read More

Bristol Myers Squibb Co Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Bristol Myers Squibb Co against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $119M x 1.1x
Abbvie Inc. ABBV ██% $365.42B 86.5x x
Abcellera Biologics Inc. ABCL ██% $1.33B x 1.4x
Abeona Therapeutics Inc. ABEO ██% $299M 4.2x 1.9x
Abbott Laboratories ABT ██% $155.82B 24.8x 3.0x
Arbutus Biopharma Corp ABUS ██% $832M x 10.9x
Abvc Biopharma, Inc. ABVC ██% $26M x 2.3x
Abivax S.A. ABVX ██% $9.24B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.74B 9.6x 3.1x
Adicet Bio, Inc. ACET ██% $77M x 0.5x
Aclaris Therapeutics, Inc. ACRS ██% $616M x 6.0x
Acrivon Therapeutics, Inc. ACRV ██% $81M x 0.7x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $6M x 1.2x
Adagene Inc. ADAG ██% $252M x 6.7x
Adc Therapeutics Sa ADCT ██% $482M x x
Adial Pharmaceuticals, Inc. ADIL ██% $2M x 0.4x
Aditxt, Inc. ADTX ██% $180K x 0.0x
Addex Therapeutics Ltd. ADXN ██% $9M x x
Aeon Biopharma, Inc. AEON ██% $23M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.67B x 1.5x
Ainos, Inc. AIMD ██% $12M x 1.7x
Akebia Therapeutics, Inc. AKBA ██% $372M x 11.4x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $6M x 0.2x
Aldeyra Therapeutics, Inc. ALDX ██% $96M x 2.2x
Alkermes Plc. ALKS ██% $5.53B 22.9x 3.0x
Allarity Therapeutics, Inc. ALLR ██% $21M x 2.1x
Alumis Inc. ALMS ██% $3.20B x 10.6x
Alnylam Pharmaceuticals, Inc. ALNY ██% $39.20B 124.9x 49.7x
Altimmune, Inc. ALT ██% $548M x 2.4x
Alx Oncology Holdings Inc ALXO ██% $227M x 8.8x
Alzamend Neuro, Inc. ALZN ██% $4M x 2.0x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.76B x 5.8x
Amphastar Pharmaceuticals, Inc. AMPH ██% $999M 10.2x 1.3x
Amarin Corp Plc\Uk AMRN ██% $295M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.02B 55.8x x
Anaptysbio, Inc ANAB ██% $1.94B x 52.2x
Anebulo Pharmaceuticals, Inc. ANEB ██% $19M x 2.4x
Ani Pharmaceuticals Inc ANIP ██% $1.81B 23.1x 3.3x
Anixa Biosciences Inc ANIX ██% $105M x 7.0x
Annexon, Inc. ANNX ██% $859M x 4.1x
Alto Neuroscience, Inc. ANRO ██% $796M x 5.3x
An2 Therapeutics, Inc. ANTX ██% $168M x 3.2x
Annovis Bio, Inc. ANVS ██% $69M x 4.1x
Apollomics Inc. APLM ██% $36M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.24B 234.2x 14.2x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $10M x 0.8x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $2M x 0.3x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.3x
Aquestive Therapeutics, Inc. AQST ██% $513M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $245M x 1.2x
Ardelyx, Inc. ARDX ██% $1.70B x 11.4x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.88B x 15.2x
Artelo Biosciences, Inc. ARTL ██% $3M x x
Arvinas, Inc. ARVN ██% $667M x 1.5x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $10.28B 50.8x 18.1x
Aspire Biopharma Holdings, Inc. ASBP ██% $1M x x
Assembly Biosciences, Inc. ASMB ██% $434M x 2.1x
Ascendis Pharma A/S ASND ██% $13.69B x x
Assertio Holdings, Inc. ASRT ██% $119M x 1.3x
Atai Beckley N.V. ATAI ██% $1.52B x 9.5x
Alterity Therapeutics Ltd ATHE ██% $89M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $35M x 4.5x
Atossa Therapeutics, Inc. ATOS ██% $46M x 1.2x
Avenue Therapeutics, Inc. ATXI ██% $2M x 0.9x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.03B 7.1x 3.5x
Arrivent Biopharma, Inc. AVBP ██% $1.27B x 4.1x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $436M x 1.6x
Avalo Therapeutics, Inc. AVTX ██% $312M x 3.8x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $10.51B x 119.0x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M x 1.1x
Bridgebio Pharma, Inc. BBIO ██% $13.35B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $671M x 1.6x
Bicara Therapeutics Inc. BCAX ██% $1.42B x 3.5x
Briacell Therapeutics Corp. BCTX ██% $30M x 1.0x
Bicycle Therapeutics Plc BCYC ██% $335M x 0.6x
Bioadaptives, Inc. BDPT ██% $150K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $13M x 6.0x
Biofrontera Inc. BFRI ██% $13M x 1.2x
Bio Green Med Solution, Inc. BGMS ██% $5M x 0.8x
Bausch Health Companies Inc. BHC ██% $2.11B x x
Bioharvest Sciences Inc. BHST ██% $95M x 3.7x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $745M x 2.7x
Bio Essence Corp BIOE ██% $19M 21.2x x
Biovie Inc. BIVI ██% $13M x 0.7x
Bioxytran, Inc BIXT ██% $3M x x
Biolinerx Ltd. BLRX ██% $13M x x
Belite Bio, Inc BLTE ██% $6.09B x 7.9x
Biomea Fusion, Inc. BMEA ██% $99M x 3.4x
Biomarin Pharmaceutical Inc BMRN ██% $10.40B 29.8x 1.7x
Bristol Myers Squibb Co BMY ██% $118.65B 16.3x 5.9x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $409M x 2.2x
Boundless Bio, Inc. BOLD ██% $35M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $10M x 0.4x
Bio-Path Holdings, Inc. BPTH ██% $510K x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $27M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $3M x x
Bioxcel Therapeutics, Inc. BTAI ██% $32M x x
Beyondspring Inc. BYSI ██% $60M x x
Calcimedica, Inc. CALC ██% $9M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $6M x 1.1x
Capricor Therapeutics, Inc. CAPR ██% $1.77B x 5.8x
Carisma Therapeutics Inc. CARM ██% $20K 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $439M x 2.1x
Gyre Therapeutics, Inc. CBIO ██% $550M 55.7x 5.2x
Cdt Equity Inc. CDT ██% $11M x 2.6x
Cingulate Inc. CING ██% $66M x 26.2x
Cell Source, Inc. CLCS ██% $57M x x
Clene Inc. CLNN ██% $67M x x
Cellectar Biosciences, Inc. CLRB ██% $11M x 1.3x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $2M x x
Climb Bio, Inc. CLYM ██% $426M x 2.7x
Chemomab Therapeutics Ltd. CMMB ██% $12M x 0.9x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $1.22B x x
Cnbx Pharmaceuticals Inc. CNBX ██% $340K x x
Cns Pharmaceuticals, Inc. CNSP ██% $2M x 0.4x
Centessa Pharmaceuticals Plc CNTA ██% $5.90B x 11.2x
Connect Biopharma Holdings Ltd CNTB ██% $139M x 3.3x
Canton Strategic Holdings, Inc. CNTN ██% $183M x 0.5x
Context Therapeutics Inc. CNTX ██% $209M x 3.5x
Cocrystal Pharma, Inc. COCP ██% $19M x 3.0x
Cogent Biosciences, Inc. COGT ██% $5.90B x 9.3x
Collegium Pharmaceutical, Inc COLL ██% $1.09B 17.3x 3.6x
Corcept Therapeutics Inc CORT ██% $5.37B 113.4x 8.4x
Coya Therapeutics, Inc. COYA ██% $98M x 2.3x
China Pharma Holdings, Inc. CPHI ██% $21M x 2.6x
Cumberland Pharmaceuticals Inc CPIX ██% $65M x 2.6x
Cannapharmarx, Inc. CPMD ██% $2M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.52B 16.4x 3.7x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $181M x 1.2x
Cormedix Inc. CRMD ██% $617M 3.8x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.73B x 3.8x
Cervomed Inc. CRVO ██% $34M x 1.9x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.30B x 21.2x
Cytomx Therapeutics, Inc. CTMX ██% $904M x 9.1x
Contineum Therapeutics, Inc. CTNM ██% $493M x 1.9x
Citius Oncology, Inc. CTOR ██% $80M x 1.4x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $5M x 6.3x
Citius Pharmaceuticals, Inc. CTXR ██% $19M x 0.2x
Cue Biopharma, Inc. CUE ██% $99M x 3.8x
Curanex Pharmaceuticals Inc CURX ██% $10M x 0.9x
Cadrenal Therapeutics, Inc. CVKD ██% $20M x 7.1x
Cv Sciences, Inc. CVSI ██% $6M x 3.8x
Cyclerion Therapeutics, Inc. CYCN ██% $14M x 1.6x
Cytodyn Inc. CYDY ██% $410M x x
Cypherpunk Technologies Inc. CYPH ██% $95M 19.7x 0.6x
Cryoport, Inc. CYRX ██% $516M 6.6x 1.0x
Cytokinetics Inc CYTK ██% $7.87B x x
Dare Bioscience, Inc. DARE ██% $34M x 11.9x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.5x
Journey Medical Corp DERM ██% $173M x 5.4x
Diamedica Therapeutics Inc. DMAC ██% $332M x 5.9x
Damora Therapeutics, Inc. DMRA ██% $1.53B x 6.4x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.76B x 9.7x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.9x
Bright Minds Biosciences Inc. DRUG ██% $851M x x
Design Therapeutics, Inc. DSGN ██% $830M x 3.8x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $49M x 0.7x
Dyne Therapeutics, Inc. DYN ██% $2.87B x 3.0x
Emergent Biosolutions Inc. EBS ██% $439M x 0.8x
Edesa Biotech, Inc. EDSA ██% $147M x 10.5x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $11M x 1.4x
Elanco Animal Health Inc ELAN ██% $11.19B x 1.7x
Eledon Pharmaceuticals, Inc. ELDN ██% $278M x 3.4x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $375M 13.7x 4.7x
Elicio Therapeutics, Inc. ELTX ██% $201M x 122.9x
Enliven Therapeutics, Inc. ELVN ██% $2.48B x 5.4x
Emmaus Life Sciences, Inc. EMMA ██% $590K x x
Enlivex Ltd. ENLV ██% $197M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $4M x 1.1x
Enanta Pharmaceuticals Inc ENTA ██% $416M x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $8M x 1.9x
Evolus, Inc. EOLS ██% $346M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $485M x 5.9x
Equillium, Inc. EQ ██% $128M x 4.5x
Erasca, Inc. ERAS ██% $2.85B x 8.8x
Ernexa Therapeutics Inc. ERNA ██% $180K x 0.1x
Esperion Therapeutics, Inc. ESPR ██% $801M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $782M x 29.9x
Earth Science Tech, Inc. ETST ██% $41M 10.1x 7.1x
Evofem Biosciences, Inc. EVFM ██% $850K 2.2x x
Evommune, Inc. EVMN ██% $882M x 4.3x
Edgewise Therapeutics, Inc. EWTX ██% $3.25B x 6.2x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $73M 10.7x 1.5x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $7M x 2.6x
Forte Biosciences, Inc. FBRX ██% $577M x 9.5x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $270M x x
Filana Therapeutics, Inc. FLNA ██% $73M x 1.0x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $490M x 1.5x
Galectin Therapeutics Inc GALT ██% $148M x x
Gain Therapeutics, Inc. GANX ██% $79M x 4.3x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $170K x x
Cytomed Therapeutics Ltd GDTC ██% $12M x x
Geron Corp GERN ██% $1.01B x 4.5x
Gh Research Plc GHRS ██% $1.28B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.2x
Galapagos Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $327M x 149.6x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $123M x 10.6x
Genprex, Inc. GNPX ██% $10M x 1.2x
Gossamer Bio, Inc. GOSS ██% $86M x x
Geovax Labs, Inc. GOVX ██% $3M x 0.7x
Structure Therapeutics Inc. GPCR ██% $3.00B x 2.0x
Grace Therapeutics, Inc. GRCE ██% $36M x 0.6x
Gridai Technologies Corp. GRDX ██% $8M x 0.4x
Gri Bio, Inc. GRI ██% $3M x 0.5x
Galera Therapeutics, Inc. GRTX ██% $14M 0.1x 3.6x
Gsk Plc GSK ██% $103.01B x x
Gt Biopharma, Inc. GTBP ██% $12M x 2.1x
Gyre Therapeutics, Inc. GYRE ██% $712M 72.1x 6.7x
Hutchmed (China) Ltd HCM ██% $2.29B 2.5x 1.9x
Hcw Biologics Inc. HCWB ██% $3M x 1.1x
Cybin Inc. HELP ██% $257M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 0.7x
Vyome Holdings, Inc HIND ██% $14M x 5.6x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $15M x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $14M x 2.3x
Werewolf Therapeutics, Inc. HOWL ██% $35M x 1.4x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.84B 11.6x 2.1x
Heron Therapeutics, Inc. /De/ HRTX ██% $239M x 16.7x
Hst Global, Inc. HSTC ██% $140M x 113.0x
Tuhura Biosciences, Inc./Nv HURA ██% $148M x 7.1x
Mindwalk Holdings Corp. HYFT ██% $57M x x
Hyperion Defi, Inc. HYPD ██% $48M x 1.2x
Ibio, Inc. IBIO ██% $57M x 1.0x
Impact Biomedical Inc. IBO ██% $71M x 5.6x
Ideaya Biosciences, Inc. IDYA ██% $2.47B x 2.4x
Inflarx N.V. IFRX ██% $152M x x
Igc Pharma, Inc. IGC ██% $31M x 4.2x
Immutep Ltd IMMP ██% $65M x x
Immix Biopharma, Inc. IMMX ██% $492M x 5.3x
Immunome Inc. IMNM ██% $2.57B x 4.1x
Imunon, Inc. IMNN ██% $11M x 1.6x
Immuron Ltd IMRN ██% $6M x x
Immuneering Corp IMRX ██% $347M x 1.6x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $131M x x
Integrated Biopharma Inc INBP ██% $7M x 0.4x
Indaptus Therapeutics, Inc. INDP ██% $5M x 1.5x
Indivior Pharmaceuticals, Inc. INDV ██% $4.67B 18.5x x
Inmed Pharmaceuticals Inc. INM ██% $2M x 0.3x
Inovio Pharmaceuticals, Inc. INO ██% $90M x 3.7x
Insmed Inc INSM ██% $28.55B x 38.6x
Inhibitor Therapeutics, Inc. INTI ██% $16M x x
Innoviva, Inc. INVA ██% $1.71B 6.3x 1.5x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $420K x 0.5x
Ionis Pharmaceuticals Inc IONS ██% $12.49B x 25.4x
Opus Genetics, Inc. IRD ██% $359M x 23.4x
Disc Medicine, Inc. IRON ██% $2.54B x 3.4x
Ironwood Pharmaceuticals Inc IRWD ██% $724M 30.1x x
International Stem Cell Corp ISCO ██% $2M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $1.03B x x
Incannex Healthcare Inc. IXHL ██% $64M x 0.9x
Jaguar Health, Inc. JAGX ██% $2M x 0.4x
Janux Therapeutics, Inc. JANX ██% $866M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $12.72B x 2.9x
Jade Biosciences, Inc. JBIO ██% $1.20B x 3.6x
Johnson & Johnson JNJ ██% $547.23B 26.0x 6.7x
Jupiter Neurosciences, Inc. JUNS ██% $14M x 246.4x
Kala Bio, Inc. KALA ██% $101M x x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.37B x x
Kairos Pharma, Ltd. KAPA ██% $12M x 1.9x
Kaya Holdings, Inc. KAYS ██% $23M x x
Kamada Ltd KMDA ██% $474M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $4.23B 57.9x 7.0x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $198M x x
Keros Therapeutics, Inc. KROS ██% $225M 2.6x 0.7x
Korro Bio, Inc. KRRO ██% $196M x 3.8x
Pasithea Therapeutics Corp. KTTA ██% $19M x 0.4x
Kura Oncology, Inc. KURA ██% $770M x 4.4x
Kyntra Bio, Inc. KYNB ██% $29M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $901M x 3.0x
Legend Biotech Corp LEGN ██% $4.36B x x
Lexaria Bioscience Corp. LEXX ██% $18M x 2.7x
Lifecore Biomedical, Inc. \De\ LFCR ██% $197M x x
Lifevantage Corp LFVN ██% $69M 8.8x 2.1x
Ligand Pharmaceuticals Inc LGND ██% $2.76B 22.2x 2.7x
Longeveron Inc. LGVN ██% $25M x 4.4x
Lianbio LIANY ██% $13M x 0.1x
Lftd Partners Inc. LIFD ██% $3M 39.3x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $100K x 0.1x
Lite Strategy, Inc. LITS ██% $42M x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $39M x 4.1x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $861.70B 34.1x 27.6x
Lunai Bioworks Inc. LNAI ██% $12M 7.2x x
Lipocine Inc. LPCN ██% $19M x 1.3x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.33B x 74.3x
Larimar Therapeutics, Inc. LRMR ██% $409M x 5.2x
Lisata Therapeutics, Inc. LSTA ██% $28M x 1.9x
Lantern Pharma Inc. LTRN ██% $24M x 3.7x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $724M x 6.7x
Lyell Immunopharma, Inc. LYEL ██% $443M x 1.8x
Maia Biotechnology, Inc. MAIA ██% $81M x 34.2x
Mustang Bio, Inc. MBIO ██% $6M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $13M x 0.9x
Mbx Biosciences, Inc. MBX ██% $1.34B x 3.6x
Seres Therapeutics, Inc. MCRB ██% $73M 12.8x 1.7x
Medicus Pharma Ltd. MDCX ██% $12M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $11.73B x 19.5x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $198M x 3.6x
Mira Pharmaceuticals, Inc. MIRA ██% $44M x 4.2x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.89B x 18.7x
Milestone Pharmaceuticals Inc. MIST ██% $199M x 4.8x
Moonlake Immunotherapeutics MLTX ██% $1.22B x 4.0x
Mineralys Therapeutics, Inc. MLYS ██% $2.39B x 3.7x
Mannkind Corp MNKD ██% $874M 149.1x x
Medicinova Inc MNOV ██% $69M x 1.7x
Monopar Therapeutics MNPR ██% $356M x 2.6x
Maplight Therapeutics, Inc. MPLT ██% $1.31B x 2.9x
Mereo Biopharma Group Plc MREO ██% $42M x 1.0x
Merck & Co., Inc. MRK ██% $280.62B 15.4x 5.3x
Marker Therapeutics, Inc. MRKR ██% $24M x 1.5x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.38B x 6.5x
Matinas Biopharma Holdings, Inc. MTNB ██% $4M x 0.9x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $7M x 1.4x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.25B x 4.8x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $467M 23.9x 2.9x
Novabridge Biosciences NBP ██% $275M x 1.1x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $21M x 37.9x
Nucana Plc NCNA ██% $9M x x
Minerva Neurosciences, Inc. NERV ██% $266M x x
Neuphoria Therapeutics Inc. NEUP ██% $28M x 1.0x
Neurogene Inc. NGNE ██% $416M x 1.6x
Nika Pharmaceuticals, Inc NIKA ██% $421M x x
Nektar Therapeutics NKTR ██% $2.92B x 32.5x
Nkarta, Inc. NKTX ██% $208M x 0.7x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $28M x 2.5x
Nurix Therapeutics, Inc. NRIX ██% $1.74B x 3.6x
Neurosense Therapeutics Ltd. NRSN ██% $29M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $98M x x
Neonc Technologies Holdings, Inc. NTHI ██% $102M x x
Nuvation Bio Inc. NUVB ██% $1.52B x 5.0x
Nuvalent, Inc. NUVL ██% $7.29B x 5.8x
Nuvectis Pharma, Inc. NVCT ██% $219M x 11.9x
Novartis Ag NVS ██% $282.12B x x
Northwest Biotherapeutics Inc NWBO ██% $321M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $32M x 0.9x
Nexentis Technologies Inc. NXTS ██% $3M x 0.2x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $2.02B x 3.1x
Oragenics Inc OGEN ██% $3M x 0.3x
Organigram Global Inc. OGI ██% $198M x x
Organon & Co. OGN ██% $3.45B 18.5x 4.6x
Onkure Therapeutics, Inc. OKUR ██% $216M x 3.9x
Olema Pharmaceuticals, Inc. OLMA ██% $1.17B x 2.5x
Omeros Corp OMER ██% $1.05B x x
Beone Medicines Ltd. ONC ██% $32.81B 114.4x 7.5x
Onconetix, Inc. ONCO ██% $7M x 0.5x
Oncolytics Biotech Inc ONCY ██% $102M x x
Opko Health, Inc. OPK ██% $858M x 0.7x
Organogenesis Holdings Inc. ORGO ██% $298M 8.1x 1.0x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $973M x 2.5x
Oruka Therapeutics, Inc. ORKA ██% $4.09B x 8.7x
Oramed Pharmaceuticals Inc. ORMP ██% $152M 2.4x 0.8x
Os Therapies Inc OSTX ██% $74M x x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 2.0x
Ovid Therapeutics Inc. OVID ██% $484M x 3.7x
One World Products, Inc. OWPC ██% $620K x x
Phibro Animal Health Corp PAHC ██% $2.16B 25.3x 6.5x
Prestige Consumer Healthcare Inc. PBH ██% $2.65B 14.2x 1.5x
Psyence Biomedical Ltd. PBM ██% $15M x x
Puma Biotechnology, Inc. PBYI ██% $379M 12.2x 2.9x
Pacira Biosciences, Inc. PCRX ██% $1.00B 195.0x 1.5x
Processa Pharmaceuticals, Inc. PCSA ██% $7M x 1.2x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $54M x 5.9x
Pepgen Inc. PEPG ██% $113M x 0.8x
Pfizer Inc PFE ██% $151.74B 19.5x 1.8x
Precigen, Inc. PGEN ██% $1.47B x 70.4x
Phathom Pharmaceuticals, Inc. PHAT ██% $890M x x
Phio Pharmaceuticals Corp. PHIO ██% $14M x 0.7x
Pharvaris N.V. PHVS ██% $2.03B x x
Protokinetix, Inc. PKTX ██% $2M x 8.4x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $75M x 0.4x
Polomar Health Services, Inc. PMHS ██% $3M x 0.4x
Promis Neurosciences Inc. PMN ██% $99M x x
Pmv Pharmaceuticals, Inc. PMVP ██% $74M x 0.7x
Purple Biotech Ltd. PPBT ██% $6M x x
Propanc Biopharma, Inc. PPCB ██% $2M x 0.2x
Praxis Precision Medicines, Inc. PRAX ██% $8.03B x 9.2x
Prf Technologies Ltd. PRFX ██% $2M x 0.2x
Perrigo Co Plc PRGO ██% $1.63B x 0.6x
Prelude Therapeutics Inc PRLD ██% $402M x 5.9x
Prophase Labs, Inc. PRPH ██% $620K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $165M x x
Prothena Corp Public Ltd Co PRTA ██% $595M x 2.1x
Ptc Therapeutics, Inc. PTCT ██% $5.30B 7.8x x
Protagonist Therapeutics, Inc PTGX ██% $6.16B x 10.0x
Protagenic Therapeutics, Inc.\New PTIX ██% $2M x x
Palatin Technologies Inc PTN ██% $37M x 3.3x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $300K 0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.2x
Provectus Biopharmaceuticals, Inc. PVCT ██% $24M x x
Palvella Therapeutics, Inc. PVLA ██% $1.84B x 65.6x
Pyxis Oncology, Inc. PYXS ██% $107M x 2.0x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $12M x 0.9x
Quantum Biopharma Ltd. QNTM ██% $33M x x
Q32 Bio Inc. QTTB ██% $95M 3.2x 2.3x
Quantum Cyber N.V. QUCY ██% $5M x 8.3x
Uniqure N.V. QURE ██% $1.24B x 6.3x
Radiopharm Theranostics Ltd RADX ██% $34M x x
Rani Therapeutics Holdings, Inc. RANI ██% $111M x 3.4x
Rapport Therapeutics, Inc. RAPP ██% $1.58B x 3.3x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.39B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $377M x 1.4x
Arcus Biosciences, Inc. RCUS ██% $3.20B x 5.1x
Dr Reddys Laboratories Ltd RDY ██% $11.39B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $73.25B 16.6x 2.3x
Revelation Biosciences, Inc. REVB ██% $4M x 0.5x
Rafael Holdings, Inc. RFL ██% $65M x 0.8x
Regen Biopharma Inc RGBP ██% $60K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $529M 1.4x 1.4x
Relmada Therapeutics, Inc. RLMD ██% $801M x 9.3x
Rallybio Corp RLYB ██% $48M x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $27M x x
Rockwell Medical, Inc. RMTI ██% $35M x 0.9x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $178M x x
Transcode Therapeutics, Inc. RNAZ ██% $7M x 5.2x
Rein Therapeutics, Inc. RNTX ██% $37M x 2.2x
Renovorx, Inc. RNXT ██% $38M x 7.1x
Roivant Sciences Ltd. ROIV ██% $20.25B x 4.7x
Royalty Pharma Plc RPRX ██% $29.69B 38.5x 4.6x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $11M x 1.3x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.47B x 39.3x
Rezolute, Inc. RZLT ██% $318M x 2.5x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $5M x 0.2x
Scienture Holdings, Inc. SCNX ██% $16M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $74M x 1.5x
Stablecoin Development Corp SDEV ██% $33M x x
Schrodinger, Inc. SDGR ██% $878M x 2.4x
Septerna, Inc. SEPN ██% $1.06B x 2.8x
Serina Therapeutics, Inc. SER ██% $27M x x
Sagimet Biosciences Inc. SGMT ██% $496M x 4.5x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $6M x 2.6x
Siga Technologies Inc SIGA ██% $329M 14.2x 1.7x
Silo Pharma, Inc. SILO ██% $7M x 1.1x
Sionna Therapeutics, Inc. SION ██% $1.73B x 5.6x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $29M x 1.5x
Sol-Gel Technologies Ltd. SLGL ██% $240M x 10.5x
Silence Therapeutics Plc SLN ██% $345M x 5.5x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.75B 131.8x 6.1x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $913M x 12.9x
Summit Therapeutics Inc. SMMT ██% $16.65B x 30.5x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.84B x x
Syndax Pharmaceuticals Inc SNDX ██% $1.90B x 45.6x
Soligenix, Inc. SNGX ██% $4M x 0.7x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $34M x 1.8x
Sanofi SNY ██% $111.60B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $155M x 3.6x
Scisparc Ltd. SPRC ██% $5M x x
Spero Therapeutics, Inc. SPRO ██% $142M 16.5x 2.4x
Ars Pharmaceuticals, Inc. SPRY ██% $820M x 7.2x
Sarepta Therapeutics, Inc. SRPT ██% $2.19B x 1.9x
Stoke Therapeutics, Inc. STOK ██% $1.93B x 5.5x
Shattuck Labs, Inc. STTK ██% $540M x 6.6x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.76B x 2.6x
Savara Inc SVRA ██% $1.07B x 5.3x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 1.2x
Synlogic, Inc. SYBX ██% $7M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $5.82B x 8.1x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $52.70B x x
Theravance Biopharma, Inc. TBPH ██% $852M 8.1x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $6M x 2.9x
Telomir Pharmaceuticals, Inc. TELO ██% $96M x 16.3x
Tenax Therapeutics, Inc. TENX ██% $338M x 3.5x
Terns Pharmaceuticals, Inc. TERN ██% $6.11B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $40.84B 26.1x 5.0x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $5.25B 11.7x 8.1x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $45M x 2.6x
Telix Pharmaceuticals Ltd TLX ██% $3.73B x x
Tango Therapeutics, Inc. TNGX ██% $2.98B x 8.6x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $166M x 0.7x
Theriva Biologics, Inc. TOVX ██% $17M x 1.1x
Tempest Therapeutics, Inc. TPST ██% $29M x 4.4x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $513M x 1.7x
Trevi Therapeutics, Inc. TRVI ██% $1.77B x 9.7x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $111M x 23.7x
Tvardi Therapeutics, Inc. TVRD ██% $29M x 1.4x
Travere Therapeutics, Inc. TVTX ██% $3.94B x 34.3x
Therapeuticsmd, Inc. TXMD ██% $24M x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.84B x 7.1x
Unicycive Therapeutics, Inc. UNCY ██% $192M x 6.4x
Upstream Bio, Inc. UPB ██% $501M x 1.5x
Urogen Pharma Ltd. URGN ██% $1.17B x x
United Therapeutics Corp UTHR ██% $24.92B 18.7x 3.5x
Vaccinex, Inc. VCNX ██% $2M x x
Vera Therapeutics, Inc. VERA ██% $2.54B x 4.2x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vg Life Sciences Inc. VGLS ██% $660K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.54B x 7.1x
Vanda Pharmaceuticals Inc. VNDA ██% $423M x 1.3x
Verrica Pharmaceuticals Inc. VRCA ██% $111M x 4.5x
Viridian Therapeutics, Inc.\De VRDN ██% $1.35B x 1.9x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $108.15B 27.4x 5.8x
Verastem, Inc. VSTM ██% $488M x 8.5x
Vistagen Therapeutics, Inc. VTGN ██% $26M x 0.5x
Viatris Inc VTRS ██% $17.40B x 1.1x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $21M x 0.8x
Whitehawk Therapeutics, Inc. WHWK ██% $182M x 1.3x
Wave Life Sciences Ltd. WVE ██% $1.36B x 2.7x
Xenetic Biosciences, Inc. XBIO ██% $7M x 0.9x
Xbiotech Inc. XBIT ██% $78M x 0.6x
Exicure, Inc. XCUR ██% $20M x 5.2x
Xenon Pharmaceuticals Inc. XENE ██% $5.52B x 9.5x
Xeris Biopharma Holdings, Inc. XERS ██% $1.05B 1887.0x 76.4x
Xilio Therapeutics, Inc. XLO ██% $50M x 1.4x
Xencor Inc XNCR ██% $898M x 1.4x
Xoma Royalty Corp XOMA ██% $485M 15.3x 5.8x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $9M x x
Zenas Biopharma, Inc. ZBIO ██% $1.20B x 5.0x
Zai Lab Ltd ZLAB ██% $2.42B x 3.4x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $280M x 1.3x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $48.76B 18.2x 14.6x
Zevra Therapeutics, Inc. ZVRA ██% $575M 6.9x 3.7x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Bristol Myers Squibb Co Stock Forecast

How accurate are Bristol Myers Squibb Co stock predictions?

Our AI model shows a 9% Spearman correlation coefficient for BMYMP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Bristol Myers Squibb Co stock price forecasts?

Our analysis considers Bristol Myers Squibb Co's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Bristol Myers Squibb Co a good investment in 2025?

Based on our AI analysis, Bristol Myers Squibb Co shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Bristol Myers Squibb Co forecasts updated?

Bristol Myers Squibb Co stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Bristol Myers Squibb Co?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...